Lumosa Therapeutics Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Taipei Taiwan (2001)

Organization Overview

First Clinical Trial
2012
NCT02468128
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Lumosa Phase 1 unit | Lumosa Therapeutics | Lumosa Therapeutics Co., Ltd.